HY4PET
LIVE

Serial Number

79354552

Owner

Hy2Care B.V.

Attorney

Bradley M. Stohry

Filing Date

Aug 17, 2022

Add to watchlist:

No watchlists yet
View on USPTO

HY4PET Trademark

Serial Number: 79354552 • Registration: 7369549

HY4PET is a trademark filed by Hy2Care B.V. on August 17, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Hy2Care B.V. (3 trademarks)

Urmonderbaan 22

Entity Type: 26

Trademark Details

Filing Date

August 17, 2022

Registration Date

April 30, 2024

Published for Opposition

February 13, 2024

Goods & Services

Medical devices, namely, injection needles; medical devices, namely, syringes; medical devices for injection of liquid components in the animal body, namely, injection needles; medical devices for injection of liquid polymers in the animal body, namely, injection needles; medical devices for injection of hydrogels in the animal body, namely, injection needles; medical devices for supply of pharmaceutical products for cartilage repair to the animal body, namely, injection instruments with needles; medical devices for supply of pharmaceutical products for bone repair to the animal body, namely, injection instruments with needles; medical devices for supply of dental fillers to the animal body, namely, injection needles; medical devices for supply of dental fillers to the animal body, namely, syringes; medical devices for application of surgical glues and sealants to the animal body; diagnostic apparatus for medical purposes, namely, ultrasound diagnostic apparatus; diagnostic apparatus for medical purposes, namely, X-ray diagnostic apparatus; cell culture instruments for medical use, namely, cell culture chambers

Medical services, namely, cartilage repair in the animal body; medical services, namely, pain management and inflammation reduction in the animal body; medical services, namely, bone repair in the animal body; dermatology services for the animal body; dentistry services for the animal body; veterinary dentistry services; surgical treatment services, namely, surgery of the animal body; veterinary surgical services; medical services for the diagnosis of conditions of the animal body; drug screening of the animal body for medical purposes; drug screening of the animal body for medical purposes involving application of liquid polymers; drug screening of the animal body for medical purposes involving application of hydrogels

Pharmaceutical compositions for cartilage repair and treatments; pharmaceutical compositions for pain management and inflammation reduction; pharmaceutical compositions for bone repair; pharmaceutical gels for cartilage repair and treatments; pharmaceutical gels for pain management and inflammation reduction; pharmaceutical gels for bone repair; injectable pharmaceuticals for cartilage repair and treatments; injectable pharmaceuticals for pain management and inflammation reduction; injectable pharmaceuticals for bone repair; pharmaceutical products containing liquid polymers for cartilage repair and treatments; pharmaceutical products containing liquid polymers for pain management and inflammation reduction; pharmaceutical products containing liquid polymers for bone repair; pharmaceutical products containing hydrogels for cartilage repair and treatments; pharmaceutical products containing hydrogels for pain management and inflammation reduction; pharmaceutical products containing hydrogels for bone repair; advanced therapy medicinal products for cartilage repair and treatments; advanced therapy medicinal products for pain management and inflammation reduction; advanced therapy medicinal products for bone repair; advanced therapy medicinal products containing liquid polymers for cartilage repair and treatments; advanced therapy medicinal products containing liquid polymers for pain management and inflammation reduction; advanced therapy medicinal products containing liquid polymers for bone repair; advanced therapy medicinal products containing hydrogels for cartilage repair and treatments; advanced therapy medicinal products containing hydrogels for pain management and inflammation reduction; advanced therapy medicinal products containing hydrogels for bone repair; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; medicated hydrogels for cartilage repair and treatments; medicated hydrogels for pain management and inflammation reduction; medicated hydrogels for bone repair; medicated hydrogels resorbable by the animal body for cartilage repair and treatments; medicated hydrogels resorbable by the animal body for pain management and inflammation reduction; medicated hydrogels resorbable by the animal body for bone repair; pharmaceutical products for cartilage repair and treatments; pharmaceutical products for pain management and inflammation reduction; pharmaceutical products for bone repair; injectable dermal fillers; dental fillers, namely, teeth filling material; surgical glues and sealants

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 30, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 9, 2025 FICS
FINAL DISPOSITION PROCESSED
Nov 8, 2025 FIMP
NEW REPRESENTATIVE AT IB RECEIVED
Oct 24, 2025 NREP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 7, 2025 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Jun 6, 2025 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 21, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 21, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 21, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 21, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 21, 2025 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 30, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 30, 2024 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 29, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 10, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 10, 2024 OPNR
NOTIFICATION PROCESSED BY IB
Feb 14, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 13, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 13, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 24, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 24, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 24, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 5, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 28, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 27, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 27, 2023 TROA
REFUSAL PROCESSED BY IB
Aug 1, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 12, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jul 12, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 8, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jun 7, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 5, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 18, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 14, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 10, 2022 REPR